1. Home
  2. LEGN vs OLED Comparison

LEGN vs OLED Comparison

Compare LEGN & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • OLED
  • Stock Information
  • Founded
  • LEGN 2014
  • OLED 1985
  • Country
  • LEGN United States
  • OLED United States
  • Employees
  • LEGN N/A
  • OLED N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • OLED Semiconductors
  • Sector
  • LEGN Health Care
  • OLED Technology
  • Exchange
  • LEGN Nasdaq
  • OLED Nasdaq
  • Market Cap
  • LEGN 7.0B
  • OLED 7.2B
  • IPO Year
  • LEGN 2020
  • OLED 1992
  • Fundamental
  • Price
  • LEGN $37.19
  • OLED $149.65
  • Analyst Decision
  • LEGN Strong Buy
  • OLED Strong Buy
  • Analyst Count
  • LEGN 12
  • OLED 7
  • Target Price
  • LEGN $79.50
  • OLED $190.43
  • AVG Volume (30 Days)
  • LEGN 1.2M
  • OLED 801.3K
  • Earning Date
  • LEGN 03-11-2025
  • OLED 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • OLED 1.18%
  • EPS Growth
  • LEGN N/A
  • OLED 9.67
  • EPS
  • LEGN N/A
  • OLED 4.65
  • Revenue
  • LEGN $627,241,000.00
  • OLED $647,684,000.00
  • Revenue This Year
  • LEGN $121.45
  • OLED $6.19
  • Revenue Next Year
  • LEGN $65.49
  • OLED $14.44
  • P/E Ratio
  • LEGN N/A
  • OLED $32.30
  • Revenue Growth
  • LEGN 119.97
  • OLED 12.36
  • 52 Week Low
  • LEGN $30.17
  • OLED $140.17
  • 52 Week High
  • LEGN $69.24
  • OLED $237.00
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 54.69
  • OLED 48.64
  • Support Level
  • LEGN $33.94
  • OLED $147.75
  • Resistance Level
  • LEGN $35.77
  • OLED $160.34
  • Average True Range (ATR)
  • LEGN 1.82
  • OLED 7.02
  • MACD
  • LEGN -0.11
  • OLED 0.21
  • Stochastic Oscillator
  • LEGN 61.16
  • OLED 26.98

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: